# HIPEC in the Treatment of Stage IIc-IV Epithelial Ovarian Cancer After CRS (HIPECOC)

> **NCT04280185** · NA · UNKNOWN · sponsor: **Second Affiliated Hospital, School of Medicine, Zhejiang University** · enrollment: 202 (estimated)

## Conditions studied

- Ovarian Cancer
- Hyperthermic Intraperitoneal Chemotherapy

## Interventions

- **PROCEDURE:** Hyperthermic Intraperitoneal Chemotherapy

## Key facts

- **NCT ID:** NCT04280185
- **Lead sponsor:** Second Affiliated Hospital, School of Medicine, Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-01
- **Primary completion:** 2022-05-01
- **Final completion:** 2024-05-01
- **Target enrollment:** 202 (ESTIMATED)
- **Last updated:** 2020-05-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04280185

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04280185, "HIPEC in the Treatment of Stage IIc-IV Epithelial Ovarian Cancer After CRS (HIPECOC)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04280185. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*